IP Library Granted Patent US 8,216,850
Granted Patent B2
US 8,216,850 · App. 13/209,073 · Granted Jul 10, 2012

DNA-based molecular switches and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,216,850
App. No.
13/209,073
Granted
Jul 10, 2012
Kind
B2
Abstract

Disclosed are nucleic acid-based molecular switches that respond to changes in pH. The switches may be used in DNA nanodevices. The switches may also act as sensors for measuring the pH of a sample, including cells, regions thereof, and whole organisms. The switch includes an A-motif that forms at acidic pH. Also disclosed are compositions and methods for measuring the pH of cells or regions thereof, such as vesicles, the nucleus, mitochondrial matrix, or the Golgi lumen.

Claims (23)

1. A method for determining the pH of a sample, the method comprising:

contacting the sample with one or more indicators having at least two poly dA nucleic acids comprising a signaling system, wherein the one or more indicators transition between first and second stable conformations in response to a change in pH; and

detecting the presence, absence, or magnitude of a signal from the signaling system to determine the pH of the sample,

wherein the signaling system comprises an interacting label pair.

2. The method of claim 1 , wherein the interacting label pair comprises a fluorophore and quencher pair.

3. The method of claim 2 , wherein the fluorophore and the quencher are on separate poly dA nucleic acids, such that a difference in a fluorescent signal is detectable upon a change in conformation of the one or more indicators.

4. A method for determining the pH of a cell or region thereof, the method comprising:

contacting the cell with one or more indicators having at least two poly dA nucleic acids comprising a signaling system, wherein the one or more indicators transition between first and second stable conformations in response to a change in pH; and

detecting the presence, absence, or magnitude of a signal from the signaling system to determine the pH of the cell or region thereof.

5. The method of claim 4 , wherein the one or more indicators further comprise one or more of a fusogenic peptide, a membrane permeabilizing peptide, a subcellular localization signal, or a cell receptor ligand.

6. The method of claim 5 , wherein the subcellular localization signal targets the indicator to a region of the cell selected from the group consisting of the cytosol, the endoplasmic reticulum, the mitochondrial matrix, the chloroplast lumen, the medial trans-Golgi cisternae, the lumen of the lysosome, and the lumen of an endosome.

7. The method of claim 5 , wherein the subcellular localization signal is selected from the group consisting of a receptor ligand, a nuclear localization signal (NLS), a nuclear export signal (NES), a plasma membrane targeting signal, a histone binding protein, and a nuclear protein.

8. The method of claim 5 , wherein the fusogenic peptide is a peptide of a viral protein derived from a virus selected from the group consisting of an influenza virus, a vesicular stomatitis virus, and an alphavirus.

9. The method of claim 5 , wherein the fusogenic peptide is a hemagglutinin of an influenza virus or a glycoprotein of a vesicular stomatitis virus.

10. The method of claim 4 , wherein the cell is a eukaryotic cell.

11. The method of claim 4 , wherein the eukaryotic cell is a mammalian cell.

12. A method of measuring endosomal maturation in a cell, the method comprising:

contacting the cell with one or more indicators having at least two poly dA nucleic acids comprising a signaling system, wherein the one or more indicators transition between first and second stable conformations in response to a change in pH, and wherein the one or more indicators comprise an endosomal targeting signal; and

detecting the presence, absence, or magnitude of a signal from the signaling system to determine the pH of the endosome.

13. The method of claim 12 , wherein the endosomal targeting signal comprises a cell-surface receptor ligand.

14. The method of claim 13 , wherein the cell-surface receptor ligand binds with its cell-surface receptor, enters the cell through receptor-mediated endocytosis, and becomes incorporated into an endosome.

15. The method of claim 14 , wherein the magnitude of the signal from the signaling system changes as the pH of the endosome changes.

16. The method of claim 15 , wherein changes in the pH of the endosome over time is an indicator of endosomal maturation.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2019
From: CRESTLINE DIRECT FINANCE, L.P.
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 049924/0794 →
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →